Literature DB >> 19216638

Transperitoneal laparoscopic repair of iatrogenic vesicovaginal fistulas: Heilbronn experience and review of the literature.

Ali Serdar Gözen1, Dogu Teber, Abdullah Erdem Canda, Jens Rassweiler.   

Abstract

BACKGROUND AND
PURPOSE: Vesicovaginal fistula (VVF) continues to be a distressing problem in urogynecology. Laparoscopy has become increasingly popular in the field of reconstructive urologic surgery. We describe our technique of laparoscopic VVF repair for iatrogenic VVFs, discuss our technique and outcomes, and review the related literature. PATIENTS AND METHODS: After hysterectomy for a benign condition, an iatrogenic VVF developed in three women (41, 48, and 34 years old, respectively) that persisted despite conservative therapy. Preoperative urethrocystoscopy demonstrated supratrigonal VVFs. Laparoscopic surgery was performed for the three patients after 3, 8, and 4 months of the previous abdominal operations. Patients were placed in a deflected supine position, and a transperitoneal five-port approach was used. The bladder was bivalved, and the fistula tract was excised. The fistulous tract was successfully repaired by closing the vagina and bladder separately. An interposing peritoneal flap was placed and fixed between the bladder and vagina.
RESULTS: The patients recovered uneventfully and were discharged from the hospital after 4, 9, and 5 days, respectively. Retrograde cystography on postoperative day 10 revealed no contrast leakage via the vagina. The urethral catheters were removed on the same day. After 30, 17, and 14 months of follow up, respectively, the patients were voiding without any urine leakage.
CONCLUSIONS: Laparoscopic repair can be applied effectively in the management of VVFs. The approach is safe and provides all advantages of minimally invasive surgery. Shorter hospital stay and shorter recovery time have a positive effect on the patients' well being.

Entities:  

Mesh:

Year:  2009        PMID: 19216638     DOI: 10.1089/end.2008.0236

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  8 in total

1.  Laparoscopic repair of iatrogenic vesicovaginal and rectovaginal fistula.

Authors:  Lei Chu; Jian-Jun Wang; Li Li; Xiao-Wen Tong; Bo-Zhen Fan; Yi Guo; Huai-Fang Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Laparoscopic transperitoneal extravesical repair of vesicovaginal fistula.

Authors:  Aly M Abdel-Karim; Ahmed Mousa; Mohamed Hasouna; Salah Elsalmy
Journal:  Int Urogynecol J       Date:  2010-11-25       Impact factor: 2.894

Review 3.  Advances in minimally invasive repair of vesicovaginal fistulas.

Authors:  Christopher F Tenggardjaja; Howard B Goldman
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

4.  Transperitoneal laparoscopic repair of vesicovaginal fistula for patients with supratrigonal fistula: comparison with open transperitoneal technique.

Authors:  Yang Xiong; Yunhua Tang; Fang Huang; Longfei Liu; Xiangyang Zhang
Journal:  Int Urogynecol J       Date:  2016-02-02       Impact factor: 2.894

Review 5.  The management of genitourinary fistula in the third millennium.

Authors:  Gamal M Ghoniem; Hussein A Warda
Journal:  Arab J Urol       Date:  2014-03-15

Review 6.  Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: A systematic review and meta-analysis.

Authors:  Barbara Bodner-Adler; Engelbert Hanzal; Eleonore Pablik; Heinz Koelbl; Klaus Bodner
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

7.  Natural Orifice Transurethral Endoscopic Vesicovaginal Fistula (NOTE-VVF) Treatment for Early and Small Fistulas: Case Report and the Point of Technique.

Authors:  Abdullah Demirtaş; Gökhan Sönmez; Şevket T Tombul; Abdullah Golbasi; Türev Demirtaş
Journal:  Cureus       Date:  2022-04-03

8.  Suprapubic transvesical laparoendoscopic single-site surgery for vesicovaginal fistula repair: a case report.

Authors:  Marek Roslan; Marcin M Markuszewski; Joanna Bagińska; Kazimierz Krajka
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2012-09-29       Impact factor: 1.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.